ÂÜÀòÂÒÂ×

Kara Malcolm is a seasoned clinical scientist with extensive experience in clinical research and development. Currently serving as the Senior Director at ImmunoGen, Inc. since January 2018, Kara oversees clinical research support, protocol development, and regulatory submissions for various programs. Prior to this role, Kara held positions at Novartis Institutes for BioMedical Research, contributing to the execution and management of complex clinical trials, and at Newton-Wellesley Hospital where responsibilities included research nursing and clinical trial management. Educational credentials were obtained from Framingham Union Hospital School of Nursing.